ars-pharma.com (SPRY): Prakiraan wutah bathi resik saben saham kanggo taun ngarep
The growth foundation of ARS Pharmaceuticals (SPRY) is based on high-margin, patented needle-free epinephrine. The history of earnings per share (EPS) expectation changes on the general GURU.Markets platform chart confirms this potential, where the current figure is 59.50. Development relies on the uniqueness of the Neffy spray in emergency medicine and the professionalism of CEO Richard Leventhal, who ensured a precise product launch.
SPRY (ars-pharma.com): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- rincian nilai buku perusahaan:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas ARS Pharmaceuticals|SPRY - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ARS Pharmaceuticals, Inc.|SPRY - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku ARS Pharmaceuticals|SPRY - Kewajiban jangka dawa|Utang jangka cendhak perusahaan ARS Pharmaceuticals|Rasio cepet ars-pharma.com
- informasi bathi lan kelipatan valuasi:
SPRY - Bathi resik|Bathi sing dikarepake ARS Pharmaceuticals|SPRY - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep ARS Pharmaceuticals|SPRY - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA ARS Pharmaceuticals|SPRY - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) ARS Pharmaceuticals|SPRY - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ars-pharma.com|SPRY - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ARS Pharmaceuticals
Pambiji fundamental perusahaan:SPRY, ARS Pharma
This indicator measures the expected change in earnings per share, reflecting the sensitivity of future cash flows to the cost of capital and market expectations. In the context of the expansion of the revolutionary nasal spray from ARS Pharmaceuticals (SPRY), the projected n+1 earnings per share dynamics visualize the company's transition from the investment stage to a phase of explosive product commercialization.
Karo sapa ARS Pharmaceuticals saingan
HLN (Haleon Group) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kenvue Health KVUE|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep LGND (Ligand)|Prakiraan wutah bathi kanggo taun ngarep Amneal Pharmaceuticals, Inc. AMRX|PRGO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep ALVO (Alvotech Biopharmaceuticals)|Liquidia Corporation (LQDA) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|GLPG - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep ANIP|MNKD: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amphastar (AMPH)|PCRX: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep TBPH (Theravance Biopharma)|Dinamika bathi saben saham sing diarepake ing taun ngarep AQST|scPharma - Prakiraan wutah bathi kanggo taun ngarep|TECX - Prakiraan wutah bathi kanggo taun ngarep|Tonix Pharmaceuticals Inc. (TNXP) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|China SXT Pharmaceuticals, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Eupraxia Pharmaceuticals, Inc.|Prakiraan wutah bathi saben saham kanggo taun ngarep bioharvest.com (BHST)|Prakiraan wutah bathi kanggo taun ngarep EXOZ|Prakiraan wutah bathi kanggo taun ngarep oramed.com (ORMP)|Prakiraan wutah bathi kanggo taun ngarep ENTX (Entera Bio)|HYFT - Prakiraan wutah bathi saben saham kanggo taun ngarep|ABVC BioPharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep cumberlandpharma.com|QNTM (Quantum BioPharma) - Prakiraan wutah bathi saben saham kanggo taun ngarep|FibroGen Inc (FGEN) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep TELO|RANI (Rani Therapeutics Inc) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SNYR|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep rallybio.com|Prakiraan wutah bathi kanggo taun ngarep LEXX (Lexaria Bioscience Corp.)|PULM - Prakiraan wutah bathi saben saham kanggo taun ngarep|Pheton - Prakiraan wutah bathi kanggo taun ngarep|APM - Prakiraan wutah bathi kanggo taun ngarep|Lyra Therapeutics, Inc. (LYRA) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IBO (Impact BioMedical, Inc.) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TNF Pharmaceuticals Inc.|cbdMD Corp (YCBD) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PainReform Limited (PRFX)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep altamiratherapeutics.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lipella Pharmaceuticals LIPO|OPTN (optinose.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|PIRS - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PROC (Procaps Group)|PTPI (Petros) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Qilian International Corp (QLI)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Acelyrin, Inc.|tffpharma.com - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep
